FDA
approval
· 2022-10-07
FDA Approved: TERIFLUNOMIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
Summary
FDA approved Alembic Pharmaceuticals' supplemental application for teriflunomide, granting approval of a generic product for the treatment of multiple sclerosis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)